Tema Oncology ETF
CANC
5 hedge funds and large institutions have $12.6M invested in Tema Oncology ETF in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
1% more capital invested
Capital invested by funds: $12.5M → $12.6M (+$134K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
3.1% less ownership
Funds ownership: 28.94% → 25.84% (-3.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$2.31M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.48K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$2.84M |
CANC Hedge Fund Activity: Q3 2024 in Review
5 of the 6,982 institutional investors tracked by Wall St. Rank reported a position in Tema Oncology ETF (CANC) for Q3 2024, worth a combined $12.6M — up 1.1% from $12.5M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CANC positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Thrivent Financial for Lutherans, adding an estimated $2.31M. The largest seller was Jane Street, cutting an estimated $2.84M.
- 5 institutional investors held Tema Oncology ETF (CANC) as of Q3 2024, up from 4 in Q2 2024.
- Funds reported $12.6M of Tema Oncology ETF stock for Q3 2024, up 1.1% quarter-over-quarter.
- 1 fund opened new Tema Oncology ETF positions in Q3 2024 and 0 closed out, a net change of +1 holder.
- The largest Tema Oncology ETF buyer in Q3 2024 was Thrivent Financial for Lutherans, an estimated $2.31M added.
- The largest Tema Oncology ETF seller in Q3 2024 was Jane Street, an estimated $2.84M sold.
Based on aggregated 13F filings for Q3 2024.